PAVmed Inc.

PAVM

PAVmed Inc.

PAVM

Insider Sentiment (TTM):

Last Purchase:2022-12-07Last Sale:2020-11-25Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:512,088Shares Outstanding:1,580,788Institutional Ownership Pct.:32.39%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash	-	-	-	3	4	3	-	-	-	-	-	-
Accounts Receivable Net Current	-	-	-	0	0	0	0	0	0	0	0	0
Inventory Net	-	-	-	-	-	-	-	0	1	0	0	-
Assets Current
Assets Current	5	7	3	4	5	4	2	2	30	30	24	32
Assets
Cash And Cash Equivalents At Carrying Value	4	6	2	-	-	-	1	1	25	26	20	26
Receivables Net Current	0	0	0	-	-	-	0	-	-	-	-	-
Prepaid Expense Current	1	1	1	-	-	-	1	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	1	2	2	2
Prepaid Expense And Other Assets Current	-	1	1	1	1	1	1	1	4	4	5	6
Operating Lease Right Of Use Asset	2	2	2	2	2	2	3	3	6	4	4	5
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	-	-	-	1	1	1	2
Equity Method Investments	33	36	34	32	36	47	26	26	-	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	1	1	1	1
Assets	40	45	39	38	44	53	31	31	39	37	33	42
Accounts Payable Current	1	1	1	0	0	0	1	0	1	1	2	2
Accrued Liabilities Current	2	2	2	3	3	2	5	5	7	7	7	5
Liabilities And Stockhold…
Liabilities Current
Liabilities Current	4	4	15	10	11	10	35	38	53	55	54	55
Operating Lease Liability Current	1	1	1	1	1	1	1	0	1	1	2	2
Secured Debt Current	0	0	11	7	7	7	29	32	44	46	44	45
Derivative Liabilities Current	-	-	-	-	-	-	-	-	-	-	-	0
Secured Long Term Debt	15	15	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	1	2	2	2	2	2	2	2	5	3	3	3
Liabilities	21	20	17	12	12	12	38	40	58	58	57	58
Equity
Temporary Equity
Temporary Equity Carrying Amount Attributable To P…	-	-	-	3	3	2	-	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	296	295	268	265	264	256	249	248	244	238	238	232
Stockholders Equity
Retained Earnings Accumulated Deficit	-265	-259	-259	-257	-251	-237	-255	-256	-321	-310	-294	-279
Stockholders Equity	35	40	22	23	28	3	-2	-9	-19	-21	-54	-43
Preferred Stock Value	-	-	-	-	-	-	3	3	3	3	3	3
Minority Interest	-16	-15	-12	-10	-9	-6	-5	-5	55	48	30	27
Liabilities And Stockholders Equity	40	45	39	38	44	53	31	31	39	37	33	42
Temporary Equity Par Or Stated Value Per Share	-	-	-	0.001	0.001	0.001	-	-	-	-	-	-
Temporary Equity Shares Authorized	-	-	-	20	20	20	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	-	-	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	-	-	20	20	20	20	20	20	20	20	20	20
Common Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	25	25	25	250	250	250	25	50	50	50	250	250
Common Stock Shares Issued	6	6	1	-	-	-	0	-	-	-	-	-
Shares Outstanding	6	6	1	1	1	1	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-15.50%	-11.47%	-21.63%	-	-	-	-	-	-	-	-	-
2025	0.32%	-5.24%	-16.67%	-2.19%	-4.39%	-5.92%	-14.99%	-36.86%	-33.25%	5.19%	-24.68%	-42.33%
2024	-39.58%	-63.12%	-58.33%	36.25%	58.75%	28.37%	-11.01%	-38.26%	-39.08%	-11.25%	-18.88%	-20.12%
2023	-	-	-	41.72%	-11.04%	-19.02%	-12.30%	18.81%	-39.56%	-15.84%	-19.00%	-52.04%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.19	2.02	0.17	0.40	0.52	0.37	0.06	0.06	0.57	0.54	0.45	0.60
Quick Ratio	0.93	1.77	0.10	0.30	0.38	0.28	0.03	0.02	0.48	0.47	0.36	0.49
Working Capital	770.00K	3.75M	-12.28M	-6.27M	-5.02M	-6.14M	-33.28M	-35.43M	-23.18M	-25.44M	-29.68M	-22.04M
Leverage & Debt
Debt to Equity	1.08	0.82	0.74	0.55	0.44	0.31	-5.36	-4.25	-3.11	-2.81	-2.38	-3.65
Interest Coverage TTM	-2,054.00	-1,626.33	-1,362.88	-917.91	-1,035.69	-1,087.79	-988.60	-960.00	-290.88	-147.94	-116.80	-95.91
Debt Ratio	0.52	0.45	0.43	0.32	0.28	0.23	1.23	1.31	1.47	1.55	1.73	1.38
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.02	0.04	0.09	0.11	0.08	0.06	0.06	0.03
Days Sales Outstanding TTM	30.96	64.41	84.82	119.57	39.72	6.96	4.81	2.35	12.39	5.69	5.81	8.07
Receivables Turnover TTM	11.79	5.67	4.30	3.05	9.19	52.45	75.82	155.15	29.45	64.17	62.87	45.22
Per Share Metrics
Diluted EPS TTM	-2.83	-16.17	0.60	16.93	130.85	44.24	18.31	1.13	-251.95	-275.51	-329.15	-329.77
Free Cash Flow Per Share TTM	-1.24	-3.98	-7.81	-4.99	-19.20	-47.66	-104.24	-137.33	-157.40	-169.38	-217.09	-230.74
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-221.43%	-228.24%	-207.04%	-524.14%	-47.75%	-57.15%	-61.60%	-58.68%	-77.57%	-126.06%	-161.83%	-324.36%
Operating Profit Margin TTM	-23,841.07%	-28,700.00%	-30,712.68%	-69,634.48%	-2,640.00%	-1,801.15%	-1,485.38%	-1,380.27%	-1,557.33%	-2,069.96%	-2,805.67%	-5,083.43%
Net Profit Margin TTM	-15,826.79%	-30,064.71%	564.79%	41,913.79%	7,733.04%	3,877.12%	1,328.58%	41.32%	-2,005.54%	-2,644.89%	-3,232.59%	-5,409.37%
Growth Metrics
Net Revenue Growth (1Y)	-89.02%	-95.74%	-97.63%	-99.28%	-73.36%	-33.92%	22.15%	166.27%	378.63%	370.51%	538.54%	164.86%
Net Income Growth (1Y)	-122.47%	-133.07%	-98.99%	629.15%	-202.72%	-196.87%	-150.20%	-102.03%	-15.05%	-21.49%	-23.22%	-9.79%
EPS Growth (1Y)	-102.16%	-109.68%	-99.52%	238.47%	-151.93%	-160.64%	-137.50%	-101.52%	-35.44%	-41.56%	-36.95%	-27.63%
Valuation Metrics
P/E TTM	-2.10	-0.63	11.09	0.76	0.14	0.13	0.15	7.38	-0.10	-0.23	-0.38	-0.40
P/B TTM	1.93	0.64	0.20	0.41	0.39	0.26	-0.86	-1.31	-0.40	-0.90	-1.24	-2.08
P/S TTM	332.50	188.76	62.61	320.02	10.64	5.02	2.03	3.05	1.95	6.16	12.14	21.78
Market Cap	37.24M	16.04M	4.45M	9.28M	10.85M	10.00M	6.07M	12.29M	7.45M	18.59M	29.76M	32.99M
Enterprise Value	48.56M	24.48M	14.01M	13.08M	13.65M	13.90M	33.99M	43.58M	25.95M	38.59M	54.33M	51.57M
Calculated Values
Free Cash Flow TTM	-7.78M	-6.29M	-5.24M	-3.58M	-11.57M	-22.05M	-33.61M	-45.76M	-47.97M	-49.04M	-52.28M	-57.34M
Net Debt	11.32M	8.44M	9.56M	3.80M	2.80M	3.90M	27.92M	31.29M	18.50M	20.00M	24.56M	18.58M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-12-07Purchase

Owner: Glennon, Michael J

Title: -

Shares: 100,000

Price/Share: $0.62

Value: $62,000.00

Shares Owned: 250,000

Relationship: Director

Ownership: Direct

2021-03-18Purchase

Owner: Aklog, Lishan, Pavilion V…

Title: Chairman and CEO

Shares: 7,500

Price/Share: $4.31

Value: $32,325.00

Shares Owned: 1,105,913

Relationship: TenPercentOwner

Ownership: Direct

2020-11-25Sale

Owner: Sirovich, Matthew

Title: -

Shares: 33,203

Price/Share: $1.96

Value: $65,077.88

Shares Owned: 1,027,744

Relationship: TenPercentOwner

Ownership: Indirect

2020-11-19Sale

Owner: Sirovich, Matthew

Title: -

Shares: 75,211

Price/Share: $1.83

Value: $137,636.13

Shares Owned: 1,113,983

Relationship: TenPercentOwner

Ownership: Indirect

2020-05-29Sale

Owner: Sirovich, Matthew

Title: -

Shares: 131,082

Price/Share: $1.98

Value: $259,542.36

Shares Owned: 1,213,983

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-12-07	Glennon, Michael J	Director	-	Direct	Purchase	100,000	0.62	$62,000.00	250,000	4
2021-03-18	Aklog, Lishan, Pavilion V…	TenPercentOwner	Chairman and CEO	Direct	Purchase	7,500	4.31	$32,325.00	1,105,913	4
2020-11-25	Sirovich, Matthew	TenPercentOwner	-	Indirect	Sale	33,203	1.96	$65,077.88	1,027,744	4
2020-11-19	Sirovich, Matthew	TenPercentOwner	-	Indirect	Sale	75,211	1.83	$137,636.13	1,113,983	4
2020-05-29	Sirovich, Matthew	TenPercentOwner	-	Indirect	Sale	131,082	1.98	$259,542.36	1,213,983	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

32.39%

Inst. Shares: 512,088

Shares Outstanding: 1,580,788

2025-12-31

275.48%

Inst. Shares: 1,846,991

Shares Outstanding: 670,466

2025-09-30

207.52%

Inst. Shares: 1,489,510

Shares Outstanding: 717,766

2025-06-30

202.32%

Inst. Shares: 1,218,427

Shares Outstanding: 602,219

2025-03-31

258.46%

Inst. Shares: 1,195,493

Shares Outstanding: 462,539

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	512,088	1,580,788	32.39%
2025-12-31	1,846,991	670,466	275.48%
2025-09-30	1,489,510	717,766	207.52%
2025-06-30	1,218,427	602,219	202.32%
2025-03-31	1,195,493	462,539	258.46%
2024-12-31	1,034,909	322,407	-
2024-09-30	1,116,022	333,179	-
2024-06-30	1,075,877	304,789	-
2024-03-31	944,096	289,540	-
2023-12-31	748,035	240,810	-
2023-09-30	813,350	248,510	-
2023-06-30	600,925	231,657	259.40%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

PAVmed Inc. (PAVM) — SEC Financial Statements & Analysis

PAVmed Inc. (PAVM) is a surgical & medical instruments & apparatus company, incorporated in DE. PAVmed Inc. trades on Nasdaq as: PAVM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PAVmed Inc. reported a -89.02% year-over-year revenue growth, a Gross Profit Margin of -221.43% (TTM), a Debt-to-Equity ratio of 1.08x, a Price-to-Sales (P/S) ratio of 332.50x (TTM), a Price-to-Book (P/B) ratio of 1.93x (TTM), at a market cap of $37.24M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -89.02%
Gross Profit Margin TTM: -221.43%
Debt To Equity: 1.08x
P/S TTM: 332.50x
P/B TTM: 1.93x
Market Cap: $37.24M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PAVmed Inc. in?

PAVmed Inc. (PAVM) operates in the Surgical & Medical Instruments & Apparatus industry.

What is PAVM's market cap?

PAVmed Inc. (PAVM) has a market capitalization of $37.24M as of 2026-06-30.

What exchange does PAVM trade on?

PAVmed Inc. (PAVM) trades on the Nasdaq.

Where is PAVmed Inc. incorporated?

PAVmed Inc. is incorporated in DE.

PAVmed Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

PAVmed Inc. (PAVM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

PAVmed Inc. (PAVM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.